ArticleCardiovascular drugs and therapy2023
Comparison of Evolocumab and Ezetimibe, Both Combined with Statin Therapy, for Patients with Recent Acute Coronary Syndrome: A Cost-Effectiveness Analysis from the Chinese Healthcare Perspective.
Xiaoyu Xi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it